SciClone Pharmaceuticals Q4 net loss narrows to $3.14m
SciClone Pharmaceuticals, a biopharmaceutical company, has reported a net loss of $3.14m, or $0.07 per share, for the fourth quarter of 2008, compared with a net loss of

SciClone Pharmaceuticals, a biopharmaceutical company, has reported a net loss of $3.14m, or $0.07 per share, for the fourth quarter of 2008, compared with a net loss of

Halo Pharmaceutical, a provider of contract manufacturing, formulation development and laboratory testing services, has announced that it is establishing a new Canadian subsidiary to be called Halo Pharmaceutical

Novexel, a specialty pharmaceutical company, has announced that its most advanced injectable antibacterial, which combines the company’s broad spectrum beta lactamase inhibitor, NXL104, with the well established cephalosporin

Highlights for 2008 include the following: Launch of the Celution System into the cosmetic and reconstructive surgery market in Europe and Asia Pacific Initiation of a 70 patient

Achaogen, a clinical stage biopharmaceutical company, has received a $26.6m contract over five years from the National Institute of Allergy and Infectious Diseases, part of the National Institutes

He previously served as senior vice president and division head at SeraCare Life Sciences’ Genomics Collaborative Division (GCI), where he managed all worldwide diagnostic and pharmaceutical R&D collaborations.

KV Pharmaceutical Company, a developer and marketer of branded and generic or non-branded prescription pharmaceutical products, has entered into a consent decree with the FDA regarding the company’s

The companies have signed an agreement that enables Medrad to sell CADstream in the UK, Germany and Italy. Under the agreement, Confirma will install, train and support all

According to TomTec, SonoLiver combines in a novel way perfusion quantification tools with perfusion imaging of focal liver lesions. SonoLiver increases the diagnostic confidence and simplifies the workflow

Lab21, a provider of diagnostic products and services, has purchased the majority shareholding of Biotec Laboratories, a clinical diagnostic company with particular emphasis on infectious diseases, most notably